The role of E3 ubiquitin ligase Cbl proteins in β-Elemene reversing multi-drug resistance of human gastric adenocarcinoma cells

46Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Recent studies indicate that β-elemene, a compound isolated from the Chinese herbal medicine Curcuma wenyujin, is capable of reversing tumor MDR, although the mechanism remains elusive. In this study, β-Elemene treatment markedly increased the intracellular accumulation of doxorubicin (DOX) and rhodamine 123 in both K562/DNR and SGC7901/ADR cells and significantly inhibited the expression of P-gp. Treatment of SGC7901/ADR cells with β-elemene led to downregulation of Akt phosphorylation and significant upregulation of the E3 ubiquitin ligases, c-Cbl and Cbl-b. Importantly, β-elemene significantly enhanced the anti-tumor activity of DOX in nude mice bearing SGC7901/ADR xenografts. Taken together, our results suggest that β-elemene may target P-gp-overexpressing leukemia and gastric cancer cells to enhance the efficacy of DOX treatment. © 2013 by the authors; licensee MDPI, Basel, Switzerland.

Cite

CITATION STYLE

APA

Zhang, Y., Mu, X. D., Li, E. Z., Luo, Y., Song, N., Qu, X. J., … Liu, Y. P. (2013). The role of E3 ubiquitin ligase Cbl proteins in β-Elemene reversing multi-drug resistance of human gastric adenocarcinoma cells. International Journal of Molecular Sciences, 14(5), 10075–10089. https://doi.org/10.3390/ijms140510075

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free